Related Experiment Video
Updated: May 21, 2026
06:24
Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
Acid phosphatase locus 1 genetic polymorphism and cancer grading
Fulvia Gloria-Bottini1, Claudio Spina, Maria Nicotra
1Division of Human Populations Biopathology and Environmental Pathology, Department of Biopathology and Imaging Diagnostics, School of Medicine, University of Rome Tor Vergata, Rome, Italy. gloria@med.uniroma2.it
The American Journal of the Medical Sciences
|June 14, 2012
Summary
Genetic variations in acid phosphatase locus 1 (ACP(1)) are linked to cancer grade in colon and endometrium cancers. Specifically, ACP(1) genotypes with the *C allele are less common in low-grade tumors, suggesting a role in cancer aggressiveness.
Area of Science:
- Genetics
- Oncology
- Biochemistry
Background:
- Growing interest in the link between acid phosphatase locus 1 (ACP(1)) and cancer.
- ACP(1) is an enzyme crucial for growth factor modulation and cellular metabolism.
- The relationship between ACP(1) genetic variability and cancer grading remains unexplored.
Purpose of the Study:
- To investigate the association between ACP(1) genotype and cancer grade.
- To analyze this relationship in colon and endometrium cancers.
Main Methods:
- Studied 71 colon cancer and 71 endometrium cancer patients.
- Determined ACP(1) genotype using DNA analysis.
- Employed three-way contingency table analysis and SPSS for statistical analysis.
Main Results:
- A significant association was found between ACP(1) and cancer grade.
- ACP(1) genotypes with the *C allele were less frequent in low-grade cancers compared to high-grade.
- ACP(1) S isoform concentration was lower in low-grade than high-grade cancers for both tumor types.
Conclusions:
- The relationship between ACP(1) and cancer grade is consistent across colon and endometrium cancers.
- ACP(1)'s role in modulating growth factors and metabolism may impact less aggressive cancer forms.
- Further research into ACP(1) and cancer aggressiveness is warranted.
More Related Videos
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:58Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...